You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 2, February 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Psychiatry
 •Obsessive-Compulsive Disorder
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

REGULAR CORRESPONDENCE
Gambling and Parkinson Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Dodd et al1 described 11 patients with Parkinson disease who developed pathological gambling. The authors concluded that because pramipexole was the agonist involved in 9 of the 11 cases, and in 10 of 17 cases reported in the literature, pramipexole may result in gambling to a higher degree as compared with the other agonists, due to its disproportionate stimulation of dopamine D3 receptors.

However, although the majority of patients with pathological gambling were taking pramipexole in this study, the total number of patients who were treated with the various agonists was not reported. If many more patients were treated with pramipexole as compared with the other 2 agonists (which is the case in many centers in North America), then it may appear that pramipexole is more responsible than the other agonists unless the denominator (total number of treated patients) is included in the assessment. Similarly, the small . . . [Full Text of this Article]

AUTHOR INFORMATION

Cathy Lu, BSc; Aamir Bharmal; Oksana Suchowersky, MD, FRCPC, FCCMG


RELATED ARTICLE

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
M. Leann Dodd, Kevin J. Klos, James H. Bower, Yonas E. Geda, Keith A. Josephs, and J. Eric Ahlskog
Arch Neurol. 2005;62(9):1377-1381.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease
Voon and Fox
Arch Neurol 2007;64:1089-1096.
ABSTRACT | FULL TEXT  

Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease
Smeding et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:517-519.
ABSTRACT | FULL TEXT  

Recognition and management of neuropsychiatric complications in Parkinson's disease
Ferreri et al.
CMAJ 2006;175:1545-1552.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.